CellSeed Inc. (TYO:7776)
484.00
-8.00 (-1.63%)
Jul 14, 2025, 3:30 PM JST
CellSeed Revenue
In the year 2021, CellSeed had annual revenue of 161.00M JPY, down -19.10%. CellSeed had revenue of 33.00M in the quarter ending December 31, 2021, a decrease of -71.55%.
Revenue
161.00M
Revenue Growth
-19.10%
P/S Ratio
104.21
Revenue / Employee
3.66M
Employees
44
Market Cap
16.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 161.00M | -38.00M | -19.10% |
Dec 31, 2020 | 199.00M | -76.00M | -27.64% |
Dec 31, 2019 | 275.00M | -751.00M | -73.20% |
Dec 31, 2018 | 1.03B | 941.00M | 1,107.06% |
Dec 31, 2017 | 85.00M | -15.00M | -15.00% |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 866.03B |
Daiichi Sankyo Company | 1,886.26B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |